首页 > 最新文献

Journal of Evidence-based Integrative Medicine最新文献

英文 中文
Cassava (Manihot esculenta Crantz): A Systematic Review for the Pharmacological Activities, Traditional Uses, Nutritional Values, and Phytochemistry. 木薯:药理活性、传统用途、营养价值和植物化学的系统综述。
IF 3.5 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/2515690X231206227
Siti Raudhah Noor Shifa Putri Mohidin, Said Moshawih, Andi Hermansyah, Mohd Ikmal Asmuni, Naeem Shafqat, Long Chiau Ming

Cassava (Manihot esculenta Crantz) is considered one of the essential tuber crops, serving as a dietary staple food for various populations. This systematic review provides a comprehensive summary of the nutritional and therapeutic properties of cassava, which is an important dietary staple and traditional medicine. The review aims to evaluate and summarize the phytochemical components of cassava and their association with pharmacological activities, traditional uses, and nutritional importance in global food crises. To collect all relevant information, electronic databases; Cochrane Library, PubMed, Scopus, Web of Science, Google Scholar, and Preprint Platforms were searched for studies on cassava from inception until October 2022. A total of 1582 studies were screened, while only 34 were included in this review. The results of the review indicate that cassava has diverse pharmacological activities, including anti-bacterial, anti-cancer, anti-diabetic, anti-diarrheal, anti-inflammatory, hypocholesterolemic effects, and wound healing properties. However, more studies that aim to isolate the phytochemicals in cassava extracts and evaluate their pharmacological property are necessary to further validate their medical and nutritional values.

木薯(Manihot esculenta Crantz)被认为是重要的块茎作物之一,是各种人群的主食。这篇系统综述全面总结了木薯的营养和治疗特性,木薯是一种重要的膳食主食和传统药物。该综述旨在评估和总结木薯的植物化学成分及其与药理活性、传统用途和在全球粮食危机中的营养重要性的关系。收集所有相关信息、电子数据库;从成立到2022年10月,检索了Cochrane图书馆、PubMed、Scopus、Web of Science、谷歌学者和预印本平台对木薯的研究。共筛选了1582项研究,而本综述仅包括34项。综述结果表明,木薯具有多种药理活性,包括抗菌、抗癌、抗糖尿病、抗腹泻、抗炎、降胆固醇作用和伤口愈合特性。然而,有必要进行更多的研究,以分离木薯提取物中的植物化学物质并评估其药理特性,从而进一步验证其医学和营养价值。
{"title":"Cassava (<i>Manihot esculenta</i> Crantz): A Systematic Review for the Pharmacological Activities, Traditional Uses, Nutritional Values, and Phytochemistry.","authors":"Siti Raudhah Noor Shifa Putri Mohidin, Said Moshawih, Andi Hermansyah, Mohd Ikmal Asmuni, Naeem Shafqat, Long Chiau Ming","doi":"10.1177/2515690X231206227","DOIUrl":"10.1177/2515690X231206227","url":null,"abstract":"<p><p>Cassava (<i>Manihot esculenta</i> Crantz) is considered one of the essential tuber crops, serving as a dietary staple food for various populations. This systematic review provides a comprehensive summary of the nutritional and therapeutic properties of cassava, which is an important dietary staple and traditional medicine. The review aims to evaluate and summarize the phytochemical components of cassava and their association with pharmacological activities, traditional uses, and nutritional importance in global food crises. To collect all relevant information, electronic databases; Cochrane Library, PubMed, Scopus, Web of Science, Google Scholar, and Preprint Platforms were searched for studies on cassava from inception until October 2022. A total of 1582 studies were screened, while only 34 were included in this review. The results of the review indicate that cassava has diverse pharmacological activities, including anti-bacterial, anti-cancer, anti-diabetic, anti-diarrheal, anti-inflammatory, hypocholesterolemic effects, and wound healing properties. However, more studies that aim to isolate the phytochemicals in cassava extracts and evaluate their pharmacological property are necessary to further validate their medical and nutritional values.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7e/eb/10.1177_2515690X231206227.PMC10571719.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41202876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Short-Term Safety Evaluation of Silbinol®- an Extract from Pterocarpus marsupium in Healthy Adults- a Randomized, Double-Blind, Placebo-Controlled Study. Silbinol®——一种从有袋翼龙中提取的提取物——在健康成年人中的短期安全性评估——一项随机、双盲、安慰剂对照研究。
IF 3.5 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/2515690X231198312
Muhammed Majeed, Kalyanam Nagabhushanam, Shaji Paulose, Lakshmi Mundkur

Background: Pterostilbene is an active molecule from the bark of the Pterocarpus marsupium tree with antioxidant and anti-inflammatory properties. Objective: This study aimed to evaluate the clinical safety of a standardized P. marsupium extract (PME) containing 90% pterostilbene (200 mg per day) in healthy adults. Methods: In a randomized, double-blind, placebo-controlled study, 60 healthy adult participants (27 males and 33 females) were randomized to receive PME-100 mg or placebo capsule twice a day for two months. The primary objectives of the study were to assess any changes in laboratory parameters, vital signs, and the occurrence of adverse events from screening to the final visit. Serum antioxidant enzyme levels were evaluated as a secondary outcome. Results: The hematological, lipid, glycemic, thyroid profiles and liver and renal functions remained within the normal range in all participants, with no difference between PME and placebo. Vital signs, including blood pressure, pulse rate, body weight, body mass index and electrocardiogram, did not reveal any significant differences between the PME and placebo groups at the beginning and end of the study. No serious adverse events were observed in any participant throughout the study period. The serum antioxidant profile was not significantly different between the treatment groups, although the glutathione levels were relatively higher in the PME group. Conclusions: Scientific evaluation of clinical safety of standardized extract is mandatory for its use as a supplement for various health benefits. The results of this study convincingly establish the safety of PME (>90% Pterostilbene) at 200 mg/day (100 mg bid) for human use. The study was approved by the Institutional Ethics Committee of BGS Global Institute of Medical Sciences & Hospital, Bangalore with the registration number CTRI/2019/08/020736.

背景:二苯乙烯是一种来自有袋翼龙树皮的活性分子,具有抗氧化和抗炎特性。目的:本研究旨在评估标准化有袋动物提取物(PME)的临床安全性,该提取物含有90%的翼替本(200 毫克/天)。方法:在一项随机、双盲、安慰剂对照研究中,60名健康成年参与者(27名男性和33名女性)被随机分配接受PME-100 mg或安慰剂胶囊,每天两次,持续两个月。该研究的主要目的是评估从筛查到最后就诊期间实验室参数、生命体征和不良事件发生率的任何变化。血清抗氧化酶水平被评估为次要结果。结果:所有参与者的血液学、脂质、血糖、甲状腺功能以及肝肾功能均保持在正常范围内,PME和安慰剂之间没有差异。生命体征,包括血压、脉搏率、体重、体重指数和心电图,在研究开始和结束时,PME组和安慰剂组之间没有显示任何显著差异。在整个研究期间,未观察到任何参与者出现严重不良事件。尽管PME组的谷胱甘肽水平相对较高,但治疗组之间的血清抗氧化剂水平没有显著差异。结论:标准化提取物作为多种健康益处的补充剂,必须对其临床安全性进行科学评估。本研究的结果令人信服地确定了PME(>90%的Pterosilbene)在200 mg/天(100 mg bid)供人类使用。该研究由班加罗尔BGS全球医学科学与医院研究所的机构伦理委员会批准,注册号为CTRI/2019/08/020736。
{"title":"A Short-Term Safety Evaluation of Silbinol<sup>®</sup>- an Extract from <i>Pterocarpus marsupium</i> in Healthy Adults- a Randomized, Double-Blind, Placebo-Controlled Study.","authors":"Muhammed Majeed, Kalyanam Nagabhushanam, Shaji Paulose, Lakshmi Mundkur","doi":"10.1177/2515690X231198312","DOIUrl":"10.1177/2515690X231198312","url":null,"abstract":"<p><p><b>Background:</b> <i>Ptero</i>stilbene is an active molecule from the bark of the <i>Pterocarpus marsupium</i> tree with antioxidant and anti-inflammatory properties. <b>Objective:</b> This study aimed to evaluate the clinical safety of a standardized <i>P. marsupium</i> extract (PME) containing 90% pterostilbene (200 mg per day) in healthy adults. <b>Methods:</b> In a randomized, double-blind, placebo-controlled study, 60 healthy adult participants (27 males and 33 females) were randomized to receive PME-100 mg or placebo capsule twice a day for two months. The primary objectives of the study were to assess any changes in laboratory parameters, vital signs, and the occurrence of adverse events from screening to the final visit. Serum antioxidant enzyme levels were evaluated as a secondary outcome. <b>Results:</b> The hematological, lipid, glycemic, thyroid profiles and liver and renal functions remained within the normal range in all participants, with no difference between PME and placebo. Vital signs, including blood pressure, pulse rate, body weight, body mass index and electrocardiogram, did not reveal any significant differences between the PME and placebo groups at the beginning and end of the study. No serious adverse events were observed in any participant throughout the study period. The serum antioxidant profile was not significantly different between the treatment groups, although the glutathione levels were relatively higher in the PME group. <b>Conclusions:</b> Scientific evaluation of clinical safety of standardized extract is mandatory for its use as a supplement for various health benefits. The results of this study convincingly establish the safety of PME (>90% Pterostilbene) at 200 mg/day (100 mg bid) for human use. The study was approved by the Institutional Ethics Committee of BGS Global Institute of Medical Sciences & Hospital, Bangalore with the registration number CTRI/2019/08/020736.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/75/98/10.1177_2515690X231198312.PMC10483972.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10189316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Vitamin D Level Between Patients with Psoriasis and Healthy Individuals: A Systematic Review and Meta-Analysis. 银屑病患者和健康人维生素D水平的比较:系统综述和荟萃分析。
IF 3.5 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/2515690X231211663
Mahmood Moosazadeh, Giovanni Damiani, Mohammad Khademloo, Motahareh Kheradmand, Fatemeh Nabinezhad-Male, Amirhossein Hessami

Background: Psoriasis is nowadays regarded as a systemic inflammatory disorder. Among the topicals, vitamin D derivates are often applied on the skin for their anti-inflammatory and immune-modulatory properties. Vitamin D serum levels in psoriasis (PsO) patients are still debated and an eventual depletion may offer the rational to integrate anti-psoriatic therapies with oral vitamin D. Then, we aimed to perform a systematic review and meta-analysis on the current evidence towards serum vitamin D level in PsO.

Methods: We searched in PubMed, Scopus, Web of Sciences, ScienceDirect and Science Information Database (SID) using the terms "Vitamin D" and "Psoriasis" including manuscripts in English, Italian and Persian. Duplications were excluded using EndNote software and records were screened by title, abstract and full-text. Quality assessment of studies was assessed using Newcastle Ottawa Checklist (NOS). Psoriasis odds ratio (OR) and mean serum vitamin D levels were calculated and displayed in Forest-plots. Heterogeneity indexes were evaluated using I2 and Q. Sensitivity analysis and publication biases were also considered.

Results: From 3006 records extracted, after removing duplicates and analyzing full texts we finally included 19 manuscripts involving a total of 1387 PsO cases and 6939 controls. PsO patients exhibited a substantial odds ratio (3.07, 95% CI: 1.56-6.04) for lower serum vitamin D levels compared to the control group. Standardized Mean Difference (SMD) of vitamin D in PsO versus controls was -0.92 (-1.33 to -0.51).

Conclusion: Psoriatic patients displayed higher risk to have a vitamin D deficiency. Interventional studies to verify the preventive value are mandatory.

背景:银屑病目前被认为是一种全身炎症性疾病。在局部用药中,维生素D衍生物因其抗炎和免疫调节特性而经常应用于皮肤。银屑病(PsO)患者的维生素D血清水平仍存在争议,最终的消耗可能为将抗银屑病治疗与口服维生素D相结合提供合理的依据。然后,我们旨在对目前关于银屑病患者血清维生素D水平的证据进行系统综述和荟萃分析。方法:我们在PubMed、Scopus、Web of Sciences,ScienceDirect和科学信息数据库(SID),使用术语“维生素D”和“银屑病”,包括英语、意大利语和波斯语的手稿。使用EndNote软件排除重复,并按标题、摘要和全文筛选记录。研究质量评估采用纽卡斯尔-渥太华检查表(NOS)进行评估。计算银屑病比值比(OR)和平均血清维生素D水平,并在Forest图中显示。使用I2和Q评估异质性指数。还考虑了敏感性分析和发表偏倚。结果:从提取的3006份记录中,在去除重复并分析全文后,我们最终纳入了19份手稿,共涉及1387例精神分裂症病例和6939例对照。与对照组相比,精神分裂症患者血清维生素D水平较低的优势比(3.07,95%CI:1.56-6.04)显著降低。银屑病患者与对照组维生素D的标准化平均差(SMD)为-0.92(-1.33至-0.51)。结论:银屑病患者维生素D缺乏的风险更高。验证预防价值的干预研究是强制性的。
{"title":"Comparing Vitamin D Level Between Patients with Psoriasis and Healthy Individuals: A Systematic Review and Meta-Analysis.","authors":"Mahmood Moosazadeh, Giovanni Damiani, Mohammad Khademloo, Motahareh Kheradmand, Fatemeh Nabinezhad-Male, Amirhossein Hessami","doi":"10.1177/2515690X231211663","DOIUrl":"10.1177/2515690X231211663","url":null,"abstract":"<p><strong>Background: </strong>Psoriasis is nowadays regarded as a systemic inflammatory disorder. Among the topicals, vitamin D derivates are often applied on the skin for their anti-inflammatory and immune-modulatory properties. Vitamin D serum levels in psoriasis (PsO) patients are still debated and an eventual depletion may offer the rational to integrate anti-psoriatic therapies with oral vitamin D. Then, we aimed to perform a systematic review and meta-analysis on the current evidence towards serum vitamin D level in PsO.</p><p><strong>Methods: </strong>We searched in PubMed, Scopus, Web of Sciences, ScienceDirect and Science Information Database (SID) using the terms \"Vitamin D\" and \"Psoriasis\" including manuscripts in English, Italian and Persian. Duplications were excluded using EndNote software and records were screened by title, abstract and full-text. Quality assessment of studies was assessed using Newcastle Ottawa Checklist (NOS). Psoriasis odds ratio (OR) and mean serum vitamin D levels were calculated and displayed in Forest-plots. Heterogeneity indexes were evaluated using <i>I</i><sup>2</sup> and Q. Sensitivity analysis and publication biases were also considered.</p><p><strong>Results: </strong>From 3006 records extracted, after removing duplicates and analyzing full texts we finally included 19 manuscripts involving a total of 1387 PsO cases and 6939 controls. PsO patients exhibited a substantial odds ratio (3.07, 95% CI: 1.56-6.04) for lower serum vitamin D levels compared to the control group. Standardized Mean Difference (SMD) of vitamin D in PsO versus controls was -0.92 (-1.33 to -0.51).</p><p><strong>Conclusion: </strong>Psoriatic patients displayed higher risk to have a vitamin D deficiency. Interventional studies to verify the preventive value are mandatory.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631321/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71482155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acupoint Transcutaneous Electrical Nerve Stimulation in Hospitalized COPD Patients with Severe Dyspnoea: A Randomized Controlled Trial. 穴位经皮电刺激治疗COPD合并严重呼吸困难住院患者:一项随机对照试验。
IF 3.5 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/2515690X231198308
Carles Fernández-Jané, Jordi Vilaró, Lluís Costa-Tutusaus

Objective: To evaluate the effect of acupuncture transcutaneous electrical nerve stimulation (acuTENS) on the reduction of dyspnoea during acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

Methods: A multicentric randomized control trial with masked patients and evaluators was carried out. During hospitalization, AECOPD patients received 45 min of acuTENS (experimental group) or sham acuTENS (controls) daily on 5 consecutive days. The trial was conducted at the Hospital del Mar, Barcelona, and Hospital Sant Joan de Déu, Manresa (both in Spain). Dyspnoea and peak expiratory flow were measured daily from the first to fifth days. Length of stay, readmissions at 3 months and adverse events were also analysed.

Results: Finally, 19 patients with moderately to severely exacerbated COPD were included. Although some tendencies in dyspnoea during day 1 and length of hospital stay were found favouring acupuncture, no significant differences were shown between groups.

Conclusions: The acuTENS intervention was feasible#well tolerated in AECOPD patients and no important side effects were reported.

目的:评价针刺经皮神经电刺激(acuTENS)减轻慢性阻塞性肺疾病(AECOPD)急性加重期呼吸困难的效果。住院期间,AECOPD患者接受了45 连续5天每天给予acuTENS分钟(实验组)或假acuTENS(对照组)。试验在巴塞罗那的德尔马医院和曼雷萨的圣琼医院(均在西班牙)进行。从第一天到第五天每天测量呼吸困难和呼气峰流量。还分析了住院时间、3个月时再次入院和不良事件。结果:最终纳入19例中度至重度COPD患者。尽管在第1天的呼吸困难和住院时间中发现了一些倾向于针灸的趋势,但各组之间没有显示出显著差异。结论:acuTENS干预对AECOPD患者是可行的,耐受性良好,无重要副作用报告。
{"title":"Acupoint Transcutaneous Electrical Nerve Stimulation in Hospitalized COPD Patients with Severe Dyspnoea: A Randomized Controlled Trial.","authors":"Carles Fernández-Jané, Jordi Vilaró, Lluís Costa-Tutusaus","doi":"10.1177/2515690X231198308","DOIUrl":"10.1177/2515690X231198308","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effect of acupuncture transcutaneous electrical nerve stimulation (acuTENS) on the reduction of dyspnoea during acute exacerbation of chronic obstructive pulmonary disease (AECOPD).</p><p><strong>Methods: </strong>A multicentric randomized control trial with masked patients and evaluators was carried out. During hospitalization, AECOPD patients received 45 min of acuTENS (experimental group) or sham acuTENS (controls) daily on 5 consecutive days. The trial was conducted at the Hospital del Mar, Barcelona, and Hospital Sant Joan de Déu, Manresa (both in Spain). Dyspnoea and peak expiratory flow were measured daily from the first to fifth days. Length of stay, readmissions at 3 months and adverse events were also analysed.</p><p><strong>Results: </strong>Finally, 19 patients with moderately to severely exacerbated COPD were included. Although some tendencies in dyspnoea during day 1 and length of hospital stay were found favouring acupuncture, no significant differences were shown between groups.</p><p><strong>Conclusions: </strong>The acuTENS intervention was feasible#well tolerated in AECOPD patients and no important side effects were reported.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/97/87/10.1177_2515690X231198308.PMC10483960.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10189313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative Phytochemical Profile and In Vitro Antioxidant Properties of Ethyl Acetate Extracts of Xerophyta spekei (Baker) and Grewia tembensis (Fresen). 贝克旱生植物(Baker)和藤芽(Grewia tembensis)乙酸乙酯提取物的定量植物化学特征及体外抗氧化性能
IF 3.5 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/2515690X231165096
Paul Nyalo, George Omwenga, Mathew Ngugi

Overproduction of free radicals in excess of antioxidants leads to oxidative stress which can cause harm to the body. Conventional antioxidants have drawbacks and are believed to be carcinogenic. The present study seeked to confirm folklore use and validate the antioxidant potentials of Grewia tembensis and Xerophyta spekei which have been widely used in the Mbeere community as medicinal plants. Antioxidant properties were determined through scavenging effects of diphenyl-1-picrylhydrazyl (DPPH) and hydrogen peroxide radicals as well as iron chelating effects. The data obtained was assayed in comparison to the standards (Ascorbic acid and EDTA). Ascorbic acid had a significantly greater DPPH radical scavenging property with an inhibitory concentration (IC50) value of 20.54 ± 2.24 µg/mL in comparison to the plant extracts, which had IC50 values of 33.00 ± 1.47 µg/mL, 69.66 ± 1.01 µg/mL and 86.88 ± 2.64 µg/mL for X. spekei, G. tembensis leaf and G. tembensis stem bark extracts, respectively. EDTA demonstrated a significantly greater iron chelating effect having a significantly lesser IC50 value of 25.05 ± 0.79 µg/mL as opposed to 43.56 ± 0.46 µg/mL, 89.78 ± 0.55 µg/mL, and 120.70 ± 0.71 µg/mL for X. spekei, G. tembensis leaf, and G. tembensis stem bark extracts respectively. Additionally, ascorbic acid also exhibited stronger hydrogen peroxide radical scavenging effect than the studied extracts. Generally, X. spekei extract had higher antioxidant activities as compared to both the leaf and stem bark extracts of G. tembensis. The phytochemical screening demonstrated the presence of secondary metabolites associated with antioxidant properties. The present study therefore, recommends ethno medicinal and therapeutic use of G. tembensis and X. spekei in the treatment and management of oxidative stress related infections.

自由基和抗氧化剂的过量产生会导致氧化应激,从而对身体造成伤害。传统的抗氧化剂有缺点,而且被认为是致癌的。本研究旨在证实作为药用植物广泛应用于Mbeere社区的绿藤(Grewia tembensis)和斑旱生植物(Xerophyta spekei)的民间用途和抗氧化潜力。通过对二苯基-1-吡啶酰肼(DPPH)和过氧化氢自由基的清除作用以及铁螯合作用来测定其抗氧化性能。将获得的数据与标准(抗坏血酸和EDTA)进行比较。抗坏血酸对DPPH自由基的清除能力显著高于植物提取物,其IC50值为20.54±2.24µg/mL,而黄芪、黄芪叶和黄芪茎皮提取物的IC50值分别为33.00±1.47µg/mL、69.66±1.01µg/mL和86.88±2.64µg/mL。EDTA对铁的螯合作用更强,IC50值为25.05±0.79µg/mL,而藤叶提取物的IC50值为43.56±0.46µg/mL,藤叶提取物的IC50值为89.78±0.55µg/mL,藤皮提取物的IC50值为120.70±0.71µg/mL, EDTA的IC50值为25.05±0.79µg/mL。此外,抗坏血酸对过氧化氢自由基的清除作用也比所研究的提取物强。总体而言,与竹叶和茎皮提取物相比,竹叶提取物具有更高的抗氧化活性。植物化学筛选表明存在与抗氧化特性相关的次级代谢物。因此,本研究建议在氧化应激相关感染的治疗和管理中,使用马蹄莲和马蹄莲进行民族医药和治疗。
{"title":"Quantitative Phytochemical Profile and <i>In Vitro</i> Antioxidant Properties of Ethyl Acetate Extracts of <i>Xerophyta spekei</i> (Baker) and <i>Grewia tembensis</i> (Fresen).","authors":"Paul Nyalo,&nbsp;George Omwenga,&nbsp;Mathew Ngugi","doi":"10.1177/2515690X231165096","DOIUrl":"https://doi.org/10.1177/2515690X231165096","url":null,"abstract":"<p><p>Overproduction of free radicals in excess of antioxidants leads to oxidative stress which can cause harm to the body. Conventional antioxidants have drawbacks and are believed to be carcinogenic. The present study seeked to confirm folklore use and validate the antioxidant potentials of <i>Grewia tembensis</i> and <i>Xerophyta spekei</i> which have been widely used in the Mbeere community as medicinal plants. Antioxidant properties were determined through scavenging effects of diphenyl-1-picrylhydrazyl (DPPH) and hydrogen peroxide radicals as well as iron chelating effects. The data obtained was assayed in comparison to the standards (Ascorbic acid and EDTA). Ascorbic acid had a significantly greater DPPH radical scavenging property with an inhibitory concentration (IC<sub>50</sub>) value of 20.54 ± 2.24 µg/mL in comparison to the plant extracts, which had IC<sub>50</sub> values of 33.00 ± 1.47 µg/mL, 69.66 ± 1.01 µg/mL and 86.88 ± 2.64 µg/mL for <i>X. spekei, G. tembensis</i> leaf and <i>G. tembensis</i> stem bark extracts, respectively. EDTA demonstrated a significantly greater iron chelating effect having a significantly lesser IC<sub>50</sub> value of 25.05 ± 0.79 µg/mL as opposed to 43.56 ± 0.46 µg/mL, 89.78 ± 0.55 µg/mL, and 120.70 ± 0.71 µg/mL for <i>X. spekei, G. tembensis</i> leaf, and <i>G. tembensis</i> stem bark extracts respectively. Additionally, ascorbic acid also exhibited stronger hydrogen peroxide radical scavenging effect than the studied extracts. Generally, <i>X. spekei</i> extract had higher antioxidant activities as compared to both the leaf and stem bark extracts of <i>G. tembensis</i>. The phytochemical screening demonstrated the presence of secondary metabolites associated with antioxidant properties. The present study therefore, recommends ethno medicinal and therapeutic use of <i>G. tembensis</i> and <i>X. spekei</i> in the treatment and management of oxidative stress related infections.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/32/6a/10.1177_2515690X231165096.PMC10034282.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9608526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Effect of Tang Forte (Royal Jelly) Capsule on Hypoglycemia and Clinical Course in COVID-19 Patients Under Corticosteroid Therapy. 唐复特(蜂王浆)胶囊对糖皮质激素治疗下新冠肺炎患者低血糖及临床病程的影响。
IF 3.5 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/2515690X231165333
Hamidreza Pourfard, Ali Ahmadi, Zahra Habibi, Majid Asadi-Samani, Najmeh Shahinfard, Akbar Soleimani

Corticosteroids improve the complications of Covid-19 but may cause some side effects such as hyperglycemia. Royal jelly is one of the bee products that exert anti-inflammatory, insulin-like, and hypoglycemic activities. The present study was conducted to investigate the effect of royal jelly capsules on blood sugar and the clinical course of Covid-19 in the patients receiving corticosteroid therapy. In this clinical trial, 72 Covid-19 patients with positive reverse transcription polymerase chain reaction (RT-PCR) test and pulmonary involvement hospitalized in Shahrekord Hajar Hospital were enrolled and randomized into two groups: treatment (receiving corticosteroids and Royal Jelly 1000 mg capsules daily for 7 days) and placebo (given corticosteroids and placebo). Laboratory tests, blood sugar, and clinical courses were determined and compared. Data was analyzed using SPSS version 16. On day 7 after the onset of the intervention, the dosage and frequency of insulin, FBS level, and required corticosteroid showed a decrease in both groups but the inter-group difference was not significant (P > .05). As well, the Spo2 level indicated a non-significant increase and hospital stay length indicated a non-significant decrease in the intervention group (P > .05). Among the symptoms, only headache, cough, and dyspnea indicated an improvement in the intervention group (P < .05). Overall, the results indicated the short-term consumption of royal jelly could not significantly improve blood sugar and the clinical course of Covid-19; however, it could significantly improve headache, cough, and dyspnea in the patients.

皮质类固醇可以改善Covid-19的并发症,但可能会引起一些副作用,如高血糖。蜂王浆是一种具有抗炎、类胰岛素和降糖作用的蜂产品。本研究旨在探讨蜂王浆胶囊对糖皮质激素治疗患者血糖及新冠肺炎临床病程的影响。本临床试验招募了在Shahrekord Hajar医院住院的72例逆转录聚合酶链反应(RT-PCR)阳性且肺部受累的Covid-19患者,随机分为两组:治疗组(每天接受皮质类固醇和蜂王浆1000 mg胶囊,连续7天)和安慰剂组(给予皮质类固醇和安慰剂)。测定并比较实验室检查、血糖和临床病程。数据分析使用SPSS version 16。干预开始后第7天,两组患者胰岛素用量、频率、FBS水平、所需皮质类固醇均下降,但组间差异无统计学意义(P > 0.05)。干预组Spo2水平无显著升高,住院时间无显著缩短(P > 0.05)。在症状中,只有头痛、咳嗽和呼吸困难在干预组有所改善(P
{"title":"The Effect of Tang Forte (Royal Jelly) Capsule on Hypoglycemia and Clinical Course in COVID-19 Patients Under Corticosteroid Therapy.","authors":"Hamidreza Pourfard,&nbsp;Ali Ahmadi,&nbsp;Zahra Habibi,&nbsp;Majid Asadi-Samani,&nbsp;Najmeh Shahinfard,&nbsp;Akbar Soleimani","doi":"10.1177/2515690X231165333","DOIUrl":"https://doi.org/10.1177/2515690X231165333","url":null,"abstract":"<p><p>Corticosteroids improve the complications of Covid-19 but may cause some side effects such as hyperglycemia. Royal jelly is one of the bee products that exert anti-inflammatory, insulin-like, and hypoglycemic activities. The present study was conducted to investigate the effect of royal jelly capsules on blood sugar and the clinical course of Covid-19 in the patients receiving corticosteroid therapy. In this clinical trial, 72 Covid-19 patients with positive reverse transcription polymerase chain reaction (RT-PCR) test and pulmonary involvement hospitalized in Shahrekord Hajar Hospital were enrolled and randomized into two groups: treatment (receiving corticosteroids and Royal Jelly 1000 mg capsules daily for 7 days) and placebo (given corticosteroids and placebo). Laboratory tests, blood sugar, and clinical courses were determined and compared. Data was analyzed using SPSS version 16. On day 7 after the onset of the intervention, the dosage and frequency of insulin, FBS level, and required corticosteroid showed a decrease in both groups but the inter-group difference was not significant (<i>P</i> > .05). As well, the Spo2 level indicated a non-significant increase and hospital stay length indicated a non-significant decrease in the intervention group (<i>P</i> > .05). Among the symptoms, only headache, cough, and dyspnea indicated an improvement in the intervention group (<i>P</i> < .05). Overall, the results indicated the short-term consumption of royal jelly could not significantly improve blood sugar and the clinical course of Covid-19; however, it could significantly improve headache, cough, and dyspnea in the patients.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2a/f5/10.1177_2515690X231165333.PMC10103254.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9615973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression. 弥漫性大B细胞淋巴瘤的临床病理特征和预后与CA-125和CA19-9表达的关系。
IF 3.5 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/2515690X231198315
Abd AlRahman Mohammad Foda, Tarek Atia, Hader I Sakr, Khaled Abd Elaziz Ahmed Elnaghi, Wagih M Abdelhay, Eman T Enan

Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non-Hodgkin lymphoma (NHL) were reported to have a close association between serum CA-125 levels and adverse prognostic factors with worse survival. We aimed to investigate CA-125 and 19-9 expression in nodal diffuse large B-cell lymphoma, not otherwise specified (DLBCL NOS) tissues using immunohistochemistry (IHC) and their relations to clinicopathological manifestations and patients' survival. Methods: 65 cases of DLBCL NOS were examined. A modified mechanical pencil tip was used to construct Manual Tissue Micro-array (TMA) blocks. Immunohistochemical staining for CA-125 and CA 19-9 was performed and scored semi-quantitatively. All relations were analyzed using established statistical methodologies. Results: Aberrant expression of CA 19-9 was detected in 12% of cases without any expression of CA-125. Moreover, 75% of the CA 19-9 positive cases were statistically significantly associated with anemia and performance status 1. Also, 75% of the CA 19-9 positive cases were females. Conclusions: CA 19-9 was aberrantly expressed in 12% of nodal DLBCL NOS cases and significantly related to anaemia and performance status but not to survival. In cases of DLBCL NOS, CA 19-9 expression cannot be considered an independent prognostic factor. CA-125 was not expressed in nodal DLBCL NOS tissues, necessitating re-evaluation studies. Therefore, it is advised to conduct more research to clarify the potential correlation between serum and tissue CA 19-9 levels and other clinic-pathological characteristics of nodal and extranodal DLBCL NOS patients.

背景:一些上皮肿瘤表达碳水化合物抗原125(癌症抗原-125,CA-125)和CA 19-9,尤其是卵巢和胰腺肿瘤。据报道,非霍奇金淋巴瘤(NHL)患者血清CA-125水平与生存率较差的不良预后因素密切相关。我们旨在利用免疫组织化学(IHC)研究CA-125和19-9在淋巴结弥漫性大B细胞淋巴瘤(DLBCL-NOS)组织中的表达及其与临床病理表现和患者生存的关系。方法:对65例DLBCL-NOS患者进行检测。使用改良的机械笔尖构建手动组织微阵列(TMA)块。对CA-125和CA19-9进行免疫组织化学染色,并进行半定量评分。使用既定的统计方法对所有关系进行了分析。结果:CA19-9异常表达率为12%,无CA125表达。此外,在CA 19-9阳性病例中,75%与贫血和表现状态1有统计学意义。此外,CA 19-9阳性病例中75%为女性。结论:CA19-9在12%的淋巴结DLBCL-NOS病例中异常表达,与贫血和工作状态显著相关,但与生存率无关。在DLBCL-NOS的病例中,CA19-9的表达不能被认为是一个独立的预后因素。CA-125在淋巴结DLBCL-NOS组织中不表达,需要重新评估研究。因此,建议进行更多的研究,以阐明结外和结外DLBCL-NOS患者血清和组织CA19-9水平与其他临床病理特征之间的潜在相关性。
{"title":"Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression.","authors":"Abd AlRahman Mohammad Foda, Tarek Atia, Hader I Sakr, Khaled Abd Elaziz Ahmed Elnaghi, Wagih M Abdelhay, Eman T Enan","doi":"10.1177/2515690X231198315","DOIUrl":"10.1177/2515690X231198315","url":null,"abstract":"<p><p><b>Background:</b> Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors. Patients with non-Hodgkin lymphoma (NHL) were reported to have a close association between serum CA-125 levels and adverse prognostic factors with worse survival. We aimed to investigate CA-125 and 19-9 expression in nodal diffuse large B-cell lymphoma, not otherwise specified (DLBCL NOS) tissues using immunohistochemistry (IHC) and their relations to clinicopathological manifestations and patients' survival. <b>Methods:</b> 65 cases of DLBCL NOS were examined. A modified mechanical pencil tip was used to construct Manual Tissue Micro-array <b>(</b>TMA) blocks. Immunohistochemical staining for CA-125 and CA 19-9 was performed and scored semi-quantitatively. All relations were analyzed using established statistical methodologies. <b>Results:</b> Aberrant expression of CA 19-9 was detected in 12% of cases without any expression of CA-125. Moreover, 75% of the CA 19-9 positive cases were statistically significantly associated with anemia and performance status 1. Also, 75% of the CA 19-9 positive cases were females. <b>Conclusions:</b> CA 19-9 was aberrantly expressed in 12% of nodal DLBCL NOS cases and significantly related to anaemia and performance status but not to survival. In cases of DLBCL NOS, CA 19-9 expression cannot be considered an independent prognostic factor. CA-125 was not expressed in nodal DLBCL NOS tissues, necessitating re-evaluation studies. Therefore, it is advised to conduct more research to clarify the potential correlation between serum and tissue CA 19-9 levels and other clinic-pathological characteristics of nodal and extranodal DLBCL NOS patients.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/30/a6/10.1177_2515690X231198315.PMC10475264.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10523569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gymnema inodorum Leaf Extract Improves Cardiac Function in Experimental Mice Infected with Plasmodium Berghei. 匙羹藤叶提取物改善伯氏疟原虫感染小鼠心脏功能。
IF 3.5 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/2515690X221150526
Sakaewan Ounjaijean, Rujikorn Rattanatham, Voravuth Somsak, Worakan Boonhoh, Sirirat Surinkaew

Malaria-associated cardiac injury has been reported to be the primary cause of death due to severe malaria. The discovery of substances showing a protective effect on cardiac injury during malaria infection is urgently needed. Hence, the purpose of this study was to evaluate the efficacy of Gymnema inodorum leaf extract (GIE) on cardiac function in mice infected with Plasmodium berghei. ICR mice were treated with 1 × 107 infected red blood cells of P. berghei ANKA (PbANKA), administered orally with GIE in 100, 250 and 500 mg/kg body weight of mice. Creatine phosphokinase (CPK) and echocardiography were carried out. It was found that CPK and heart-weight to body-weight (HW/BW) ratios were significantly higher in untreated mice than the healthy control. Moreover, impaired cardiac function in the untreated group was observed as indicated by changes in echocardiography. Interestingly, GIE exerted a protective effect on cardiac injury induced by PbANKA infection. Our results demonstrated that the parasitemia percentage, CPK, HW/BW ratio, and echocardiography in GIE treated mice were improved. However, there was no significant difference between GIE dosages. Therefore, GIE possessed a cardio-protective effect during malaria infection in mice.

据报告,与疟疾有关的心脏损伤是严重疟疾造成死亡的主要原因。迫切需要发现对疟疾感染期间心脏损伤具有保护作用的物质。因此,本研究的目的是评价木藤叶提取物(GIE)对伯氏疟原虫感染小鼠心功能的影响。用1 × 107个感染的白僵菌ANKA红血球(PbANKA)治疗ICR小鼠,分别以100、250和500 mg/kg体重给药。进行肌酸磷酸激酶(CPK)和超声心动图检查。结果发现,未处理小鼠的CPK和心脏重量与体重(HW/BW)比显著高于健康对照组。此外,通过超声心动图的变化,观察到未治疗组的心功能受损。有趣的是,GIE对PbANKA感染引起的心脏损伤有保护作用。我们的结果表明,GIE治疗小鼠的寄生虫率、CPK、HW/BW比和超声心动图均有改善。但不同剂量间无显著性差异。因此,GIE在小鼠疟疾感染期间具有心脏保护作用。
{"title":"Gymnema inodorum Leaf Extract Improves Cardiac Function in Experimental Mice Infected with Plasmodium Berghei.","authors":"Sakaewan Ounjaijean,&nbsp;Rujikorn Rattanatham,&nbsp;Voravuth Somsak,&nbsp;Worakan Boonhoh,&nbsp;Sirirat Surinkaew","doi":"10.1177/2515690X221150526","DOIUrl":"https://doi.org/10.1177/2515690X221150526","url":null,"abstract":"<p><p>Malaria-associated cardiac injury has been reported to be the primary cause of death due to severe malaria. The discovery of substances showing a protective effect on cardiac injury during malaria infection is urgently needed. Hence, the purpose of this study was to evaluate the efficacy of <i>Gymnema inodorum</i> leaf extract (GIE) on cardiac function in mice infected with <i>Plasmodium berghei</i>. ICR mice were treated with 1 × 10<sup>7</sup> infected red blood cells of <i>P. berghei</i> ANKA (PbANKA), administered orally with GIE in 100, 250 and 500 mg/kg body weight of mice. Creatine phosphokinase (CPK) and echocardiography were carried out. It was found that CPK and heart-weight to body-weight (HW/BW) ratios were significantly higher in untreated mice than the healthy control. Moreover, impaired cardiac function in the untreated group was observed as indicated by changes in echocardiography. Interestingly, GIE exerted a protective effect on cardiac injury induced by PbANKA infection. Our results demonstrated that the parasitemia percentage, CPK, HW/BW ratio, and echocardiography in GIE treated mice were improved. However, there was no significant difference between GIE dosages. Therefore, GIE possessed a cardio-protective effect during malaria infection in mice.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/8a/10.1177_2515690X221150526.PMC9834418.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9237415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
In Vitro Antiproliferative Effects and Phytochemical Characterization of Carissa edulis ((Forssk) Vahl) and Pappea capensis (Eckyl and Zeyh) Extracts. 山豆角提取物和山豆角(Eckyl和Zeyh)提取物的体外抗增殖作用和植物化学特性。
IF 3.5 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/2515690X231187711
Carolyn Wanjira Muruthi, Mathew Piero Ngugi, Steven Maina Runo, Peter Githaiga Mwitari

Cancer mortality is a global concern. The current therapeutic approaches despite showing efficacy are characterized by several limitations. Search for alternatives has led to the use of herbal plants including C. edulis and P. capensis. However, there is limited research on antiproliferative effects of these medicinal plants. The study sought to evaluate antiproliferative effects of the plants against human breast and prostate cancers using cell viability, and gene expression assays to determine modulation of apoptotic genes. Further, Liquid Chromatography Mass Spectrophotometer (LC-MS) and Gas Chromatography Mass Spectrophotometer (GC-MS) analyses were performed to confirm phytocompounds in the extracts. The results indicated that ethylacetate extracts of C. edulis and P. capensis had the highest activity against cancer cells with IC50 values of 2.12 ± 0.02, and 6.57 ± 0.03 μg/ml on HCC 1395 and 2.92 ± 0.17 and 5.00 ± 0.17 μg/ml on DU145, respectively. Moreover, the plants extracts exhibited relatively less cytotoxic activities against Vero cell lines (IC50 > 20 μg/ml). The extracts also exhibit selectivity against the cancer cells (SI > 3). Further, mRNA expression of p53 in the treated HCC 1395 was increased by 7 and 3-fold, whereas by 3 and 2-fold in DU145 cells, upon treatment with ethylacetate extracts of C. edulis and P. capensis, respectively. Similarly, several-fold increases were observed in the number of transcripts of Bax in HCC 1395 and HOXB13 in DU145 cells. Phytochemical analyses detected presence of phytocompounds including flavonoids, phenolics, tocopherols and terpenoids which are associated with anticancer activity. Findings from this study provide a scientific validation for the folklore use of these plants in management of cancer.

癌症死亡率是全球关注的问题。目前的治疗方法尽管显示出疗效,但有几个局限性。寻找替代品已经导致了包括C.edulis和P.capensis在内的草药植物的使用。然而,对这些药用植物的抗增殖作用的研究有限。该研究试图通过细胞活力和基因表达测定来评估植物对人类乳腺癌和前列腺癌的抗增殖作用,以确定凋亡基因的调节。此外,还进行了液相色谱-质谱仪(LC-MS)和气相色谱-气质联用仪(GC-MS)分析,以确认提取物中的植物化合物。结果表明,紫丁香和山核桃乙酸乙酯提取物对癌症细胞的抑制活性最高,IC50值为2.12 ± 0.02和6.57 ± 0.03 μg/ml对HCC 1395和2.92 ± 0.17和5.00 ± 0.17 μg/ml。此外,植物提取物对Vero细胞系表现出相对较小的细胞毒性活性(IC50 > 20 μg/ml)。提取物还表现出对癌症细胞的选择性(SI > 3) 。此外,在用C.edulis和P.capensis的乙酸乙酯提取物处理后,经处理的HCC 1395中p53的mRNA表达分别增加了7倍和3倍,而在DU145细胞中增加了3倍和2倍。类似地,在HCC 1395和DU145细胞中观察到Bax的转录物数量增加了数倍。植物化学分析检测到存在与抗癌活性相关的植物化合物,包括类黄酮、酚类、生育酚和萜类。这项研究的结果为民间传说中这些植物在癌症治疗中的应用提供了科学验证。
{"title":"<i>In Vitro</i> Antiproliferative Effects and Phytochemical Characterization of <i>Carissa edulis</i> ((Forssk) Vahl) and <i>Pappea capensis</i> (Eckyl and Zeyh) Extracts.","authors":"Carolyn Wanjira Muruthi, Mathew Piero Ngugi, Steven Maina Runo, Peter Githaiga Mwitari","doi":"10.1177/2515690X231187711","DOIUrl":"10.1177/2515690X231187711","url":null,"abstract":"<p><p>Cancer mortality is a global concern. The current therapeutic approaches despite showing efficacy are characterized by several limitations. Search for alternatives has led to the use of herbal plants including <i>C. edulis</i> and <i>P. capensis</i>. However, there is limited research on antiproliferative effects of these medicinal plants. The study sought to evaluate antiproliferative effects of the plants against human breast and prostate cancers using cell viability, and gene expression assays to determine modulation of apoptotic genes. Further, Liquid Chromatography Mass Spectrophotometer (LC-MS) and Gas Chromatography Mass Spectrophotometer (GC-MS) analyses were performed to confirm phytocompounds in the extracts. The results indicated that ethylacetate extracts of <i>C. edulis</i> and <i>P. capensis</i> had the highest activity against cancer cells with IC<sub>50</sub> values of 2.12 ± 0.02, and 6.57 ± 0.03 μg/ml on HCC 1395 and 2.92 ± 0.17 and 5.00 ± 0.17 μg/ml on DU145, respectively. Moreover, the plants extracts exhibited relatively less cytotoxic activities against Vero cell lines (IC<sub>50 </sub>> 20 μg/ml). The extracts also exhibit selectivity against the cancer cells (SI > 3). Further, mRNA expression of <i>p53</i> in the treated HCC 1395 was increased by 7 and 3-fold, whereas by 3 and 2-fold in DU145 cells, upon treatment with ethylacetate extracts of <i>C. edulis</i> and <i>P. capensis</i>, respectively. Similarly, several-fold increases were observed in the number of transcripts of <i>Bax</i> in HCC 1395 and HOXB13 in DU145 cells. Phytochemical analyses detected presence of phytocompounds including flavonoids, phenolics, tocopherols and terpenoids which are associated with anticancer activity. Findings from this study provide a scientific validation for the folklore use of these plants in management of cancer.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/22/4a/10.1177_2515690X231187711.PMC10387709.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9918896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognition Enhancing Potential of Aqueous Leaf Extract of Amaranthus dubius in Mice. 苋菜叶水提物对小鼠认知能力的增强作用。
IF 3.5 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/2515690X231211661
Daisy Jepkosgei Kipkemoi, Anthony Murithi Ireri, Mathew Piero Ngugi

Amaranthus dubius is a vegetable consumed for its nutritional content in Kenya. In herbal medicine, A. dubius is utilized to relief fever, anemia and hemorrhage. Additionally, it is utilized to manage cognitive dysfunction and is considered to augment brain function, but there is no empirical evidence to support this claim. The contemporary study investigated cognitive enhancing potential of A. dubius in mice model of Alzheimer's disease (AD)-like dementia induced with ketamine. Cognitively damaged mice were treated with aqueous extract of A. dubius leaf upon which passive avoidance task (PAT) was used to assess the cognitive performance. At the end of passive avoidance test, brains of the mice were dissected to evaluate the possibility of the extract to inhibit hallmarks that propagate AD namely oxidative stress and acetylcholinesterase activity. Additionally, characterization of secondary metabolites was done using liquid chromatograph- mass spectrometry analysis. During PAT test, extract-treated mice showed significantly increased step-through latencies than AD mice, depicting ability of A. dubius to reverse ketamine-induced cognitive decline. Further, the extract remarkably lowered malondialdehyde levels to normal levels and effectively inhibited acetylcholinesterase enzyme. The study showed that A. dubius extract is endowed with phytoconstituents that possess anti-oxidant and anticholinesterase activities. Thus, this study confirmed promising therapeutic effects of 200, 300 and 400 mg/kg bw of A. dubius extract with potential to alleviate cognitive disarray observed in AD.

在肯尼亚,苋菜是一种因其营养成分而被食用的蔬菜。在草药中,双歧杆菌被用来缓解发烧、贫血和出血。此外,它被用来治疗认知功能障碍,并被认为可以增强大脑功能,但没有经验证据支持这一说法。本研究对氯胺酮诱导的阿尔茨海默病(AD)样痴呆小鼠模型中双歧杆菌的认知增强潜力进行了研究。以认知损伤小鼠为研究对象,采用被动回避任务(PAT)评价认知功能。在被动回避试验结束时,解剖小鼠的大脑,以评估提取物抑制AD传播标志的可能性,即氧化应激和乙酰胆碱酯酶活性。此外,利用液相色谱-质谱分析方法对次生代谢物进行了表征。在PAT测试中,提取物处理的小鼠比阿尔茨海默病小鼠表现出显著增加的步进潜伏期,表明双角仙有能力逆转氯胺酮诱导的认知衰退。此外,提取物显著降低丙二醛水平至正常水平,并有效抑制乙酰胆碱酯酶。研究表明,双歧杆菌提取物具有抗氧化和抗胆碱酯酶活性。因此,本研究证实了200、300和400 mg/kg bw的双歧杆菌提取物有良好的治疗效果,可能减轻AD患者的认知障碍。
{"title":"Cognition Enhancing Potential of Aqueous Leaf Extract of <i>Amaranthus dubius</i> in Mice.","authors":"Daisy Jepkosgei Kipkemoi, Anthony Murithi Ireri, Mathew Piero Ngugi","doi":"10.1177/2515690X231211661","DOIUrl":"10.1177/2515690X231211661","url":null,"abstract":"<p><p><i>Amaranthus dubius</i> is a vegetable consumed for its nutritional content in Kenya. In herbal medicine, <i>A. dubius</i> is utilized to relief fever, anemia and hemorrhage. Additionally, it is utilized to manage cognitive dysfunction and is considered to augment brain function, but there is no empirical evidence to support this claim. The contemporary study investigated cognitive enhancing potential of <i>A. dubius</i> in mice model of Alzheimer's disease (AD)-like dementia induced with ketamine<i>.</i> Cognitively damaged mice were treated with aqueous extract of <i>A. dubius</i> leaf upon which passive avoidance task (PAT) was used to assess the cognitive performance. At the end of passive avoidance test, brains of the mice were dissected to evaluate the possibility of the extract to inhibit hallmarks that propagate AD namely oxidative stress and acetylcholinesterase activity. Additionally, characterization of secondary metabolites was done using liquid chromatograph- mass spectrometry analysis. During PAT test, extract-treated mice showed significantly increased step-through latencies than AD mice, depicting ability of <i>A. dubius</i> to reverse ketamine-induced cognitive decline. Further, the extract remarkably lowered malondialdehyde levels to normal levels and effectively inhibited acetylcholinesterase enzyme. The study showed that <i>A. dubius</i> extract is endowed with phytoconstituents that possess anti-oxidant and anticholinesterase activities. Thus, this study confirmed promising therapeutic effects of 200, 300 and 400 mg/kg bw of <i>A. dubius</i> extract with potential to alleviate cognitive disarray observed in AD.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":null,"pages":null},"PeriodicalIF":3.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92154724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Evidence-based Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1